Chief Accounting Officer
Arcutis Biotherapeutics, Inc. (ARQT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Scott Burrows is recorded as Chief Accounting Officer at Arcutis Biotherapeutics, Inc. (ARQT). Arcutis Biotherapeutics, Inc. reported in an 8-K filed August 18, 2023 that Scott Burrows resigned as chief financial officer, effective August 31, 2023. The proxy statement of Arcutis Biotherapeutics, Inc. reports total compensation of $1,246,136 for Scott Burrows in fiscal 2022, including a base salary of $386,667. Disclosed compensation is on record for 2 fiscal years. Scott Burrows has spoken on 4 earnings calls across 1 company, most recently for Arcutis Biotherapeutics, Inc. on August 8, 2023.
“On August 15, 2023, Scott Burrows notified Arcutis Biotherapeutics, Inc. (the "Company") of his decision to resign as chief financial officer of the Company, effective as of August 31, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2021-04-01–present
Start not stated–2023-08-31
Start not stated–2023-08-31
Recorded roles and call appearances connecting this person to public companies.
Chief Accounting Officer
2021-04-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Arcutis Biotherapeutics, Inc. (ARQT) | Chief Financial Officer | $386,667 | $1,246,136 |
| 2021 | Arcutis Biotherapeutics, Inc. (ARQT) | Chief Financial Officer | $330,750 | $2,080,377 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
